Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru digital microfinance platform providing JLG loans to Indian blue-collar workers; $9M raised with $5M CDM Capital Series A at $2.2M revenue using digital joint liability Microfinance 2.0 model.
Kosh is a Bengaluru, India-based digital lending platform providing joint liability group (JLG) loans to blue-collar workers and informal economy participants — a "Microfinance 2.0" model that combines India's traditional community-based joint liability lending structure with digital underwriting, mobile disbursement, and data-driven credit assessment. Founded and backed with $9.03 million raised total including a $5 million Series A in March 2025 led by CDM Capital with participation from LetsVenture, JAFCO Asia, Security and Intelligence Services, and Legacy Asset, Kosh generated ₹18.3 crore ($2.2 million USD) in revenue as of March 2024 with a ₹178 crore valuation.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.